What Is CVS Health Corporation (CVS) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, CVS Health Corporation presents a highly debated valuation profile at its current price of $106.18. The composite intrinsic value is estimated at $105.93 (-0.2% average upside), masking a wide model spread between the 5 bullish models and 4 bearish models. Model dispersion is worth noting: First Chicago targets $182.29 (+71.7%), versus EROIC at $44.27 (-58.3%). This +130.0% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bullish — adding weight to the bullish side of the thesis.
What Do the Models Say About CVS?
12 of 13 models are currently active for CVS. Of these, 8 models suggest upside while 4 models suggest overvaluation. The Bayesian DCF estimates CVS's intrinsic value at $113.35, implying +6.8% upside from the current price. See which stocks rank higher →
How Does CVS Rank in Retail-Drug Stores and Proprietary Stores?
Among 5 Retail-Drug Stores and Proprietary Stores stocks, CVS ranks #1 by Quality of Company score. CirclFi's QOC score of 7.6/10 evaluates 32 fundamental signals. A score of 7.6 indicates above-average quality.
The Retail-Drug Stores and Proprietary Stores sector introduces analytical considerations specific to biopharma enterprise businesses. For CVS Health Corporation, metrics like R&D productivity ratio provide important context that general-purpose valuation models may underweight.
Is CVS a Value Trap?
CirclFi's Value Trap algorithm assigns CVS a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
12 of 13 models are active for CVS Health Corporation. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, CVS Health Corporation earns a quality score of 7.6/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +130.0% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CVS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CVS's 12 active models, average confidence is 54%. Moderate confidence indicates reasonable fit.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad